Waters stock analysis
Waters (0LTI) Share Price & Analysis
0LTI Stock Chart & Stats
- Day’s Range
- $474.16 - $485.00
- 52-Week Range
- $270.00 - $489.88
- Previous Close
- $474.12
- Volume
- N/A
- Average Volume (3M)
- 624
- Market Cap
- $46.72B
- Enterprise Value
- $47.00B
- Total Cash (Recent Filing)
- $593.00M
- Total Debt (Recent Filing)
- $5.50B
- Price to Earnings (P/E)
- 200.4
- Beta
- 0.77
- Next Earnings
- Feb 17, 2027 (Est.)
- EPS Estimate
- 4.66
- Last Dividend Ex-Date
- Mar 15, 2022
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Recurring Installed-Base Revenue
Waters combines higher-value instrument sales with repeat consumables, service contracts and software revenue. Once customers standardize workflows on its platforms, ongoing utilization can support repeat purchasing and create a more durable revenue base than equipment sales alone.
Raised Growth And Synergy Outlook
Raised revenue and earnings guidance indicates management is converting current demand and integration progress into a stronger operating outlook. Planned cost and revenue synergies can support growth and margin expansion over the next several quarters if execution remains on track.
Leading Analytical Sciences Momentum
Outgrowing the life science tools market and a close peer over an extended period suggests durable customer demand and competitive execution. Continued replacement activity, complex biologics, GLP-1s, PFAS testing and generics provide multiple structural demand drivers.
Bears Say
Sharp TTM Margin Compression
The latest profitability reset materially weakens current earnings quality despite strong revenue growth. If low margins persist, Waters may have less operating leverage, reduced returns on its expanded asset base and less flexibility to absorb integration costs or invest for growth.
Weaker Cash Conversion
Waters remains cash-generative, but the recent decline in free cash flow and lower conversion from earnings indicate greater cash demands or working-capital pressure. Sustained weaker conversion could constrain debt reduction, investment capacity and the benefits of reported earnings growth.
Acquired-Business Execution Risk
Limited reported growth in the acquired businesses places greater pressure on integration, product launches and synergies to improve performance. A prolonged transition could dilute consolidated growth, delay expected benefits and make margin recovery more dependent on legacy Waters.
0LTI FAQ
What was Waters’s price range in the past 12 months?
What is Waters’s market cap?
When is Waters’s upcoming earnings report date?
How were Waters’s earnings last quarter?
Is Waters overvalued?
Does Waters pay dividends?
What is Waters’s EPS estimate?
How many shares outstanding does Waters have?
What happened to Waters’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Waters?
What is the TipRanks Smart Score and how is it calculated?
Waters Stock Smart Score
Company Description
Waters
Waters Corporation is a global leader in specialized measurement, delivering analytical solutions across Asia, the Americas, and Europe. The company operates through two main divisions: Waters and TA. Under its Waters segment, it engineers, manufactures, sells, and provides support for high and ultra-performance liquid chromatography and mass spectrometry (MS) systems. This includes essential consumables like chromatography columns and comprehensive post-warranty service plans. The TA segment focuses on designing, producing, selling, and servicing instruments for thermal analysis, rheometry, and calorimetry. Additionally, Waters develops and supplies sophisticated software that integrates with both its own instruments and those from other manufacturers. The company's advanced MS technology plays a crucial role in various applications, such as drug discovery and development (including clinical trial assessments), analyzing proteins involved in disease processes, ensuring nutritional safety, and conducting environmental testing. Its thermal analysis, rheometry, and calorimetry instruments are vital for assessing the suitability and stability of a wide range of materials, including fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids. These instruments support diverse sectors like industrial manufacturing, consumer goods, healthcare products, and life science research. Waters' extensive client base spans the life sciences, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental sectors, where its products are instrumental in research and development, quality assurance, and general laboratory operations. Established in 1958, Waters Corporation is headquartered in Milford, Massachusetts.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Udit Batra
- Employees
- 15,000
- Website
- www.waters.com
- Address
- 34 Maple Street, Milford, MA, 01757, US
Waters (0LTI) Earnings & Revenues
0LTI Company Deck
0LTI Earnings Call
Earnings Call SentimentPositive
The call was strongly positive. Highlights significantly outweighed the challenges, with double-digit organic growth, a 21% adjusted EPS increase, raised full-year revenue and EPS guidance, improving acquired-business execution, strong product and AI momentum, cost-savings progress and a constructive 2027 framework. The main negatives were limited reported growth in the acquired businesses, China DRG and channel-inventory headwinds, constrained free cash flow, elevated inventory and acquisition-related costs.
View all GB:0LTI earnings summaries0LTI Net sales Breakdown
- 34.81% Waters instrument systems
- 19.95% Chemistry consumables
- 34.13% Waters service
- 7.70% TA instrument systems
- 3.41% TA service
0LTI Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 15 | 5 | 2 |
| Technical Analysis | 3 | 5 | 2 |
| Moving Averages | 12 | 0 | 0 |












